A

Arrowhead Pharmaceuticals
D

ARWR

15.740
USD
-0.52
(-3.20%)
مغلق
حجم التداول
90,570
الربح لكل سهم
-3
العائد الربحي
-
P/E
-13
حجم السوق
2,173,700,847
أصول ذات صلة
ALNY
ALNY
1.29
(0.39%)
329.01 USD
C
CRSP
-1.350
(-2.04%)
64.760 USD
E
EDIT
-0.11000
(-3.38%)
3.14000 USD
I
IONS
0.100
(0.24%)
42.240 USD
MRNA
MRNA
0.125
(0.37%)
34.145 USD
N
NTLA
0.830
(6.50%)
13.595 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
S
SGMO
-0.01190
(-1.99%)
0.58600 USD
S
SRPT
-0.970
(-7.53%)
11.910 USD
VRTX
VRTX
-2.89
(-0.61%)
469.58 USD
المزيد
الأخبار المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.